| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88ff2961c50ec06faed6a4d3343b2acc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8849b0d1046412c1f9fedf5ffdd23a6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
| filingDate |
1993-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e4392ce179e1be5c9197a259f1851c |
| publicationDate |
1994-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9402131-A1 |
| titleOfInvention |
Treatment of herpetic diseases |
| abstract |
A method of prophylactic or therapeutic treatment of a human or animal body comprising by application of a pharmaceutically acceptable amount by oral, parenteral or topical application of zinc glycerolate for the treatment of herpetic diseases other than Herpes Simplex. The herpetic diseases may be Herpes Zoster or Genital Herpes. The application of zinc glycerolate may be as a dry powder, as a cream or ointment or applied topically by an applicator. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9428884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2239527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2283805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2316415-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004005300-A1 |
| priorityDate |
1992-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |